Dancy 4 mg (Tablet)
(24 active+4 inert) tablets: ৳ 400.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Drospirenone |
| Company | Ziska pharmaceuticals ltd |
Title
- Dancy Oral Contraceptive
- Dancy 3mg Drospirenone Tablet
Categories
- Oral Contraceptive
- Hormonal Contraceptive
- Progestin Tablet
Description
- Indicated for females as an oral contraceptive
- Reduces the risk of pregnancy primarily by suppressing ovulation
- Contains 3mg Drospirenone as the active ingredient
- Consists of white active tablets and light pink inert tablets
- Dosage involves daily intake for 28 consecutive days
Color Options
- White (active tablets)
- Light pink (inert tablets)
Dimensions
- Standard tablet size
Functions
- Prevents pregnancy
- Suppresses ovulation
- Reduces the risk of hyperkalemia
- Aids in regulating menstruation
- Affects serum potassium concentration
- Reduces bone mineral density
Materials
- Contains Drospirenone
- Albumin binding
Technical Specifications
- Drospirenone concentration: 3mg per tablet
- Absorption time: 2-6 hours after ingestion
Design Elements
- 28-day cycle packaging
- Individually marked active and inert tablets
Usability Features
- Swallow whole once a day
- Requires daily intake at the same time each day
Absorption
- Dose-proportional pharmacokinetics
- Maximum plasma concentration reached at 2-6 hours
- Steady-state concentrations reached after 10 days
Distribution
- 95-97% bound to serum albumin
- Apparent volume of distribution is approximately 4 L/kg
Metabolism
- Extensively metabolized after oral administration
- Subject to oxidative metabolism catalyzed by CYP3A4
Excretion
- Complete excretion after ten days
- Slightly higher excretion in feces than urine
Dosage & Administration
- Swallow whole once a day
- Take one tablet daily for 28 consecutive days
- Start with white active tablet on the first day of menses
Instructions for Starting
- Take first white active tablet on the first day of menses
Instructions for Switching
- Dependent on previous contraceptive method
Interactions
- Potential interactions with enzyme inducers
- May increase serum potassium concentration
Contraindications
- Renal impairment
- Adrenal insufficiency
- Presence or history of progestin sensitive cancers
- Liver tumors or hepatic impairment
- Undiagnosed abnormal uterine bleeding
Side Effects
- Acne
- Headache
- Nausea
- Vaginal hemorrhage
- Weight increased
Pregnancy & Lactation
- Little or no increased risk of birth defects if used during early pregnancy
- Negligible excretion in breast milk
Precautions & Warnings
- Hyperkalemia
- Thromboembolic Disorders
- Bone Loss
- Ectopic Pregnancy
- Risk of Hyperglycemia in Patients with Diabetes
- Bleeding Irregularities and Amenorrhea
Overdose Effects
- Symptoms may include nausea, vomiting, and vaginal bleeding
- Monitor serum potassium and sodium levels
Therapeutic Class
- Oral Contraceptive preparations
Storage Conditions
- Store below 30°C
- Keep away from light
- Keep out of the reach of children